CYC vs IMR

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

CYC

CYCLOPHARM FPO [CYC]

41LOW

IMR

IMRICOR CDI FORUS [IMR]

39LOW

Score Breakdown

CYC IMR
Technical
41
63
Catalyst
51
51
Sentiment
50
50
Fundamental
69
60
Momentum
39
58
Risk Gate
50
50

Key Metrics

CYC Metric IMR
$61.6MMarket Cap$625.5M
345KAvg Volume (20d)360K
N/AShort Interest+0.1%
$1.29052-Week High$2.250
$0.45052-Week Low$1.145
-6.7%Daily Change-3.8%
$0.490Reference Price$1.755
-49.3%ROE-1221.3%
-53.3%Profit MarginN/A

Active Signals

CYC Signals

●RSI drifting toward oversold territory — worth watching
●Volume surging at 2.7x normal while price falls — heavy selling pressure
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.5 quarters)
●Low P/S ratio (1.9x)
●Moderate revenue growth (+10%)
●EPS estimates revised upward (+10pts)

IMR Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Sitting near support — this level has held before and could attract buyers again
●Drifting lower — down 3.8% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (9 quarters)

Ask Scout AI to compare CYC and IMR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CYC vs MVF →CYC vs NEU →CYC vs PHX →CYC vs PKY →CYC vs REG →
CYC Full Analysis → IMR Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).